Read + Share
Amedeo Smart
Independent Medical Education
Cheng HS, Chong YK, Lim EKY, Lee XY, et al. Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide. Neuro Oncol 2024 Feb 16:noae028. doi: 10.1093.PMID: 38366847
Email
LinkedIn
Facebook
Twitter
Privacy Policy